NCT04490421 2021-02-08
Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.
Fuzhou General Hospital
Phase 3 Unknown
Clinical Trials
5 trialsNCT04203485 2020-05-08
Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT03651219 2018-08-29
Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer
Beijing Chest Hospital
Phase 3 Unknown
NCT02332512 2017-02-24
ANSWER
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT01287962 2013-12-09
Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 3 Unknown